ADTX Aditxt, Inc.

NEUTRAL Impact: 3/10 S-3
Horizon weeks Filed Apr 11, 2026 Processed 1mo ago SEC 0001213900-26-042708
Shelf registration — potential dilution
Latest settled — T+20d
ADTX ▼ -76.81% at T+20d
NEUTRAL call ✗ call lost -76.81% · α vs SPY -84.54% · entry $12.69 → $2.94
Next anchor: T+60d in 7w
Currently $1.40 · -88.97% from $12.69 entry
Entry anchored
Apr 10, 02:11 PM ET
via Databento tick
T+1d
-10.43%
call -10.43% · α -11.64%
$11.37
settled 5w ago
T+5d
-26.17%
call -26.17% · α -29.47%
$9.37
settled 5w ago
T+20d
-76.81%
call -76.81% · α -84.54%
$2.94
settled 12d ago
T+60d
call — · α —
in 7w

Price Chart

Loading chart...

Executive Summary

Aditxt, Inc. has filed an S-3 shelf registration to allow selling stockholders to resell up to 148,278,241 shares of common stock issuable upon exercise of various warrants. The company will not receive proceeds from the resale, but could receive up to $74.14 million if all warrants are exercised for cash. The filing is primarily for registration purposes and does not indicate an immediate offering.

Key Financial Metrics

Offering Size
$74.1M

Actionable Insight

Monitor for actual warrant exercises, as the company could receive significant cash proceeds. The shelf registration itself is routine and does not indicate immediate dilution, but creates the potential for future capital raises.

Key Facts

  • S-3 shelf registration filed for resale of up to 148,278,241 shares of common stock
  • Shares are issuable upon exercise of various warrants held by selling stockholders
  • Company will not receive proceeds from resale of shares by selling stockholders
  • Company could receive up to $74.14 million if all warrants are exercised for cash
  • Warrants have an exercise price of $0.50 per share
  • Registration is for resale purposes only, not an immediate offering

Financial Impact

Up to $74.14 million in potential proceeds if all warrants are exercised for cash

dilutioncash_flow

Risk Factors

  • Potential dilution if warrants are exercised
  • Market perception of overhang from large number of shares available for resale

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations

Documents Analyzed

This report is based on 8 SEC documents filed with EDGAR.

DocumentAccession Number
S-3 Filing (Primary)0001213900-26-042708
Document: ea028573201ex-fee.htm0001213900-26-042708
Document: ea028573201ex5-1.htm0001213900-26-042708
Document: ea028573201ex23-3.htm0001213900-26-042708
Document: ea028573201ex23-1.htm0001213900-26-042708
Document: 0001213900-26-042708-index-headers.html0001213900-26-042708
Document: 0001213900-26-042708-index.html0001213900-26-042708
Document: 0001213900-26-042708.txt0001213900-26-042708
9 reports for ADTX
Performance horizon
100% Hit rate 3 of 3 directional calls best @ T+20▲ +79.81%Apr 14, 2026
Filters
Rows
Reports for ADTX — sortable, filterable
Type Now
May 15, 2026
5d ago
8-K
NEUTRAL ★ 4/10
$0.0644 awaiting T+5awaiting T+5$1.40 (+2073.91%)
May 8, 2026
12d ago
8-K
BEARISH ★ 8/10
$2.94 $1.63▲ +44.78%▲ +44.70%$1.40 (+52.43%)
Apr 23, 2026
27d ago
3
NEUTRAL ★ 3/10
$7.80 $5.27▼ −32.53%▼ −34.00%$1.40 (−82.06%)
Apr 22, 2026
28d ago
EFFECT
NEUTRAL ★ 3/10
$8.37 $5.86▼ −30.00%▼ −30.05%$1.40 (−83.27%)
Apr 14, 2026
5w ago
8-K
BEARISH ★ 6/10
$11.37 $8.32▲ +26.84%▲ +28.23%$1.40 (+87.68%)
Apr 11, 2026
5w ago
S-3
NEUTRAL ★ 3/10
$12.69 $9.37▼ −26.17%▼ −29.47%$1.40 (−88.97%)
Apr 2, 2026
6w ago
8-K
NEUTRAL ★ 4/10
$21.44 $13.55▼ −36.78%▼ −40.39%$1.40 (−93.47%)
Mar 27, 2026
7w ago
424B5
BEARISH ★ 6/10
$21.30 $14.04▲ +34.09%▲ +38.39%$1.40 (+93.43%)
Mar 5, 2026
10w ago
8-K
NEUTRAL ★ 4/10
$93.74 $78.03▼ −16.76%▼ −14.53%$1.40 (−98.51%)
Showing 9 of 9

US Market Status

Market Closed — Opens Thu (< 1m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access